Impact of socioeconomic status on medication compliance and major adverse cardiac events (MACE) following percutaneous coronary intervention (PCI)

被引：0
|
作者：
Lefkovits, L. [1 ]
Andrianopoulos, N. [1 ]
Stub, D. [1 ]
Clark, D. J. [1 ]
Ajani, A. E. [1 ]
Brennan, A. L. [1 ]
New, G. [1 ]
Reid, C. M. [1 ]
Dart, A. M. [1 ]
Duffy, S. J. [1 ]
机构：
[1] Alfred Hosp, Melbourne, Vic, Australia
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：848 / 848
页数：1
相关论文
共 50 条
  • [41] Major adverse cardiac and cerebral events after percutaneous coronary intervention. A real world multicentre registry
    Livarek, B
    Lefevre, T
    Fosse, S
    EUROPEAN HEART JOURNAL, 2003, 24 : 583 - 583
  • [42] Influence of incentive telephone follow-up on adverse cardiovascular events and medication compliance of patients after percutaneous coronary intervention
    Du, Rui
    Gao, Jingyi
    Liu, Yanchun
    Wang, Limei
    Ma, Lin
    Ji, Zheng
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 107 - 107
  • [43] Stratification Analysis of Statin Effect on Major Adverse Cardiac Events After Percutaneous Coronary Intervention in Patients on Hemodialysis
    Horikoshi, Takeo
    Nakamura, Takamitsu
    Yoshizaki, Toru
    Nakamura, Jun
    Makino, Aritaka
    Saito, Yukio
    Obata, Jun-ei
    Sawanobori, Takao
    Takano, Hajime
    Umetani, Ken
    Watanabe, Akinori
    Asakawa, Tetsuya
    Kugiyama, Kiyotaka
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 168 - 176
  • [44] The problem with composite end points in cardiovascular studies - The story of major adverse cardiac events and percutaneous coronary intervention
    Kip, Kevin E.
    Hollabaugh, Kim
    Marroquin, Oscar C.
    Williams, David O.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (07) : 701 - 707
  • [45] Prognostic role of apolipoproteins on long-term major adverse cardiac events after percutaneous coronary intervention
    Kawahara, Hiroshi
    Endo, Akihiro
    Uchida, Kazuhiko
    Tanabe, Kazuaki
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 61 : 85 - 92
  • [46] Effect of postmenopausal hormone therapy on major adverse cardiac events after percutaneous coronary intervention: The HERS trial
    Khan, MA
    Shlipak, MG
    Liu, MW
    Rogers, WJ
    Lin, F
    Hlatky, MA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) : 56A - 56A
  • [47] Predicting major adverse cardiac events after percutaneous coronary intervention: The Texas Heart Institute risk score
    Madan, Pankaj
    Elayda, MacArthur A.
    Lee, Vei-Vei
    Wilson, James M.
    AMERICAN HEART JOURNAL, 2008, 155 (06) : 1068 - 1074
  • [48] Contemporary Predictors of Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention: A Nationally Representative US Sample
    Horne, Benjamin D.
    Atreja, Nipun
    Venditto, John
    Wilson, Thomas
    Muhlestein, Joseph B.
    St. Clair, Joshua R.
    Knowlton, Kirk U.
    Khan, Naeem D.
    Bhalla, Narinder
    Anderson, Jeffrey L.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [49] Operator specific outcome in percutaneous coronary intervention (PCI): Impact of risk adjustment on apparent MACE rate
    Palmer, ND
    Grayson, AD
    Beaumont, AJ
    Jackson, M
    Perry, RA
    Stables, RH
    HEART, 2004, 90 : A4 - A4
  • [50] Effect of Insurance Type on Adverse Cardiac Events After Percutaneous Coronary Intervention
    Gaglia, Michael A., Jr.
    Torguson, Rebecca
    Xue, Zhenyi
    Gonzalez, Manuel A.
    Ben-Dor, Itsik
    Maluenda, Gabriel
    Mahmoudi, Michael
    Sardi, Gabriel
    Wakabayashi, Kohei
    Kaneshige, Kimberly
    Suddath, William O.
    Kent, Kenneth M.
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (05): : 675 - 680
12345